Efficacia e tossicità di brexucabtagene autoleucel nel trattamento del linfoma mantellare ad alto rischio: descrizione di un caso clinico

Brexu-cel represents an effective treatment option even in R/R MCL with high-risk features but can be associated with prolonged toxicities. An accurate patient selection and a close monitoring during post-CAR-T follow-up is crucial in order to prolong survival of these patients.